EXEL INDUSTRIES: 2015-2016 first-half results Increased income and Strategic Acquisition in the USA
Apr 21, 2016 07:08 am UTC| Business
PARIS, April 21, 2016 -- Revenue of €309.5 million, up €11 million from February 2015. Current Operating Income (EBIT) up to €8.3 million from -€6.1 million. Net profit in the...
Real journalists report the news, they don’t make it.
Apr 21, 2016 06:35 am UTC| Insights & Views Business
At QUTs Digital Media Research Centre we are about to complete ARC-funded research on the state of the Australian political news media. A key finding of the work has been the nearly complete withdrawal of commercial...
Apr 21, 2016 06:05 am UTC| Business
MARTINSRIED / MUNICH, Germany, April 21, 2016 -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that its partner Novartis has confirmed that a phase 2b/3 study examining bimagrumab...
Ad hoc: MorphoSys Provides Update on Results From Partner's Phase 2b/3 RESILIENT Study of Bimagrumab
Apr 21, 2016 06:02 am UTC| Business
MARTINSRIED / MUNICH, Germany, April 21, 2016 -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that its partner Novartis has confirmed that a phase 2b/3 study examining bimagrumab...
Apr 21, 2016 05:23 am UTC| Business
EVRY, France, April 21, 2016 -- Global Bioenergies (Alternext Paris: ALGBE) announces having delivered isobutene produced at its industrial pilot to ARLANXEO, a world leader in high-quality synthetic rubbers headquartered...
Apr 21, 2016 05:21 am UTC| Business
Tumor checkpoint controller BAL101553 demonstrates pre-clinical activity in treatment-refractory glioblastoma models as single agent and in combination treatment PanRAF/SRC kinase inhibitor BAL3833 inhibits tumor...
ADVA Optical Networking SE: ADVA Optical Networking Increases Sales to EUR 122.0 Million in Q1 2016
Apr 21, 2016 05:15 am UTC| Business
Revenues of EUR 122.0 Million Drive 27.6% Year-on-Year Growth Pro Forma Operating Income: EUR 2.0 Million (1.6% of Revenues) Q2 2016 Outlook: Revenues EUR145 - 155 Million; Pro Forma Operating Income 1% - 4% of...